Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?

Cifaldi L, Doria M, Cotugno N, Zicari S, Cancrini C, Palma P, Rossi P.

Int J Mol Sci. 2019 Jul 30;20(15). pii: E3715. doi: 10.3390/ijms20153715. Review.

2.

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors.

Veneziani I, Fruci D, Compagnone M, Pistoia V, Rossi P, Cifaldi L.

Oncotarget. 2019 Mar 15;10(22):2151-2160. doi: 10.18632/oncotarget.26736. eCollection 2019 Mar 15.

3.

Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.

Compagnone M, Cifaldi L, Fruci D.

Hum Immunol. 2019 May;80(5):318-324. doi: 10.1016/j.humimm.2019.02.014. Epub 2019 Feb 27. Review.

PMID:
30825518
4.

Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.

Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, Fruci D.

Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019.

PMID:
30713803
5.

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.

Veneziani I, Brandetti E, Ognibene M, Pezzolo A, Pistoia V, Cifaldi L.

J Immunol Res. 2018 Apr 1;2018:4972410. doi: 10.1155/2018/4972410. eCollection 2018.

6.

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.

Perri V, Gianchecchi E, Cifaldi L, Pellegrino M, Giorda E, Andreani M, Cappa M, Fierabracci A.

PLoS One. 2017 Dec 13;12(12):e0189615. doi: 10.1371/journal.pone.0189615. eCollection 2017.

7.

Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.

Cifaldi L, Locatelli F, Marasco E, Moretta L, Pistoia V.

Trends Mol Med. 2017 Dec;23(12):1156-1175. doi: 10.1016/j.molmed.2017.10.002. Epub 2017 Nov 10. Review.

PMID:
29133133
8.

Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion.

Romania P, Cifaldi L, Pignoloni B, Starc N, D'Alicandro V, Melaiu O, Li Pira G, Giorda E, Carrozzo R, Bergvall M, Bergström T, Alfredsson L, Olsson T, Kockum I, Seppälä I, Lehtimäki T, Hurme MA, Hengel H, Santoni A, Cerboni C, Locatelli F, D'Amato M, Fruci D.

Cell Rep. 2017 Jul 25;20(4):846-853. doi: 10.1016/j.celrep.2017.06.084.

9.

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma.

Brandetti E, Veneziani I, Melaiu O, Pezzolo A, Castellano A, Boldrini R, Ferretti E, Fruci D, Moretta L, Pistoia V, Locatelli F, Cifaldi L.

Oncoimmunology. 2017 Apr 20;6(6):e1316439. doi: 10.1080/2162402X.2017.1316439. eCollection 2017.

10.

NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.

Cifaldi L, Pinto RM, Rana I, Caniglia M, Angioni A, Petrocchi S, Cancrini C, Cursi L, Palumbo G, Zingoni A, Gismondi A, Rossi P, Santoni A, Cerboni C.

Immunol Lett. 2016 Dec;180:46-53. doi: 10.1016/j.imlet.2016.10.009. Epub 2016 Nov 2.

PMID:
27816481
11.

Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.

Cifaldi L, Prencipe G, Caiello I, Bracaglia C, Locatelli F, De Benedetti F, Strippoli R.

Arthritis Rheumatol. 2015 Nov;67(11):3037-46. doi: 10.1002/art.39295.

12.

TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.

Folgiero V, Cifaldi L, Li Pira G, Goffredo BM, Vinti L, Locatelli F.

J Hematol Oncol. 2015 Apr 16;8:36. doi: 10.1186/s13045-015-0134-4.

13.

ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors.

Cifaldi L, Romania P, Falco M, Lorenzi S, Meazza R, Petrini S, Andreani M, Pende D, Locatelli F, Fruci D.

Cancer Res. 2015 Mar 1;75(5):824-34. doi: 10.1158/0008-5472.CAN-14-1643. Epub 2015 Jan 15.

14.

Demonstration of compatibility of multiple arterial blood gas syringes with current multi-parameter analyzers.

Seiberlich LE, Cifaldi LM.

Curr Med Res Opin. 2014 Jul;30(7):1375-82. doi: 10.1185/03007995.2014.904773. Epub 2014 Apr 4.

PMID:
24628565
15.

T and NK cells: two sides of tumor immunoevasion.

Fruci D, Lo Monaco E, Cifaldi L, Locatelli F, Tremante E, Benevolo M, Giacomini P.

J Transl Med. 2013 Feb 4;11:30. doi: 10.1186/1479-5876-11-30.

16.

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.

Lorenzi S, Forloni M, Cifaldi L, Antonucci C, Citti A, Boldrini R, Pezzullo M, Castellano A, Russo V, van der Bruggen P, Giacomini P, Locatelli F, Fruci D.

PLoS One. 2012;7(10):e46928. doi: 10.1371/journal.pone.0046928. Epub 2012 Oct 5.

17.

[The perceived quality of routine daily communication in dialogues between health care workers].

Felicetti V, Cifaldi L, Cristina G, Trecca P.

Clin Ter. 2012 Jul;163(4):e227-32. Review. Italian.

PMID:
23007829
18.

Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer.

Cifaldi L, Romania P, Lorenzi S, Locatelli F, Fruci D.

Int J Mol Sci. 2012;13(7):8338-52. doi: 10.3390/ijms13078338. Epub 2012 Jul 4. Review.

19.

ERAAP modulation: A possible novel strategy for cancer immunotherapy?

Fruci D, Locatelli F, Cifaldi L.

Oncoimmunology. 2012 Jan 1;1(1):81-82.

20.

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.

Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco CM, Locatelli F, Gallo A.

Oncogene. 2013 Feb 21;32(8):998-1009. doi: 10.1038/onc.2012.125. Epub 2012 Apr 23.

21.

Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma.

Pazzaglia S, Cifaldi L, Saran A, Nobili V, Fruci D, Alisi A.

Hepatology. 2012 Oct;56(4):1589. doi: 10.1002/hep.25783. No abstract available.

PMID:
22505342
22.

Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.

Fruci D, Benevolo M, Cifaldi L, Lorenzi S, Lo Monaco E, Tremante E, Giacomini P.

Curr Oncol. 2012 Feb;19(1):39-41. doi: 10.3747/co.19.945. No abstract available.

23.

Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.

Cifaldi L, Lo Monaco E, Forloni M, Giorda E, Lorenzi S, Petrini S, Tremante E, Pende D, Locatelli F, Giacomini P, Fruci D.

Cancer Res. 2011 Mar 1;71(5):1597-606. doi: 10.1158/0008-5472.CAN-10-3326. Epub 2011 Jan 20.

24.

[The second opinion in oncology].

Cifaldi L, Felicetti V, Cristina G.

Recenti Prog Med. 2010 Jul-Aug;101(7-8):299-302. Italian.

PMID:
20842957
25.

[Informed consent. Doctor and patient: comparison of view points].

Felicetti V, Manfredi Selvaggi F, Cifaldi L.

Clin Ter. 2010;161(3):227-30. Italian.

PMID:
20589351
26.

NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.

Forloni M, Albini S, Limongi MZ, Cifaldi L, Boldrini R, Nicotra MR, Giannini G, Natali PG, Giacomini P, Fruci D.

Cancer Res. 2010 Feb 1;70(3):916-24. doi: 10.1158/0008-5472.CAN-09-2582. Epub 2010 Jan 26. Erratum in: Cancer Res. 2010 Apr 1;70(7):2995.

27.

HLA-E and the origin of immunogenic self HLA epitopes.

Lo Monaco E, Tremante E, Cifaldi L, Fruci D, Giacomini P.

Mol Immunol. 2010 May;47(9):1661-2; author reply 1163-4. doi: 10.1016/j.molimm.2009.12.018. Epub 2010 Jan 22. No abstract available.

PMID:
20096934
28.

CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses.

Carbone T, Nasorri F, Pennino D, Eyerich K, Foerster S, Cifaldi L, Traidl-Hoffman C, Behrendt H, Cavani A.

J Immunol. 2010 Jan 15;184(2):1102-10. doi: 10.4049/jimmunol.0902518. Epub 2009 Dec 11.

29.

[From empowerment to customer satisfaction: experience of a medical oncology unit].

Cifaldi L, Gareri R, Cristina G, Felicetti V, Gremigni U.

Clin Ter. 2009;160(4):273-5. Italian.

PMID:
19795079
30.

[The lack of good manners in medicine: sign of the times or educational gap?].

Felicetti V, Di Pilla G, Cifaldi L.

Recenti Prog Med. 2009 May;100(5):257-8. Italian. No abstract available.

PMID:
19772217
31.

[Off-label use in oncology. The Italian choice].

Felicetti V, Gremigni U, Cifaldi L.

Recenti Prog Med. 2008 Dec;99(12):612-5. Italian.

PMID:
19388222
32.

Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I.

Eyerich K, Cifaldi L, Notarangelo LD, Porta F, Notarangelo L, Mazzolari E, Fiorini M, Paradisi A, Cavani A.

Eur J Dermatol. 2009 Jan-Feb;19(1):78-9. doi: 10.1684/ejd.2008.0552. No abstract available.

PMID:
19171538
33.

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.

Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V, Giacomini P, Peschle C, Fruci D.

PLoS One. 2008 May 21;3(5):e2236. doi: 10.1371/journal.pone.0002236.

34.

[Bioethics and pharmacoeconomics: a difficult balance].

Felicetti V, Cristina G, Cifaldi L.

Clin Ter. 2008 Jan-Feb;159(1):29-32. Review. Italian.

PMID:
18399259
35.

[Oncological disease between economic ties and a health humanization policy].

Cifaldi L, Felicetti V, Gareri R, Cristina G.

Recenti Prog Med. 2008 Jan;99(1):48-51. Review. Italian.

PMID:
18389874
36.

Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect.

Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, Jacobelli J, Bandiera E, Notarangelo L, Santoni A.

Blood. 2004 Jul 15;104(2):436-43. Epub 2004 Mar 4.

PMID:
15001467
37.

Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration.

Gismondi A, Jacobelli J, Strippoli R, Mainiero F, Soriani A, Cifaldi L, Piccoli M, Frati L, Santoni A.

J Immunol. 2003 Mar 15;170(6):3065-73.

38.

Interleukin 12-activated lymphocytes influence tumor genetic programs.

Cavallo F, Quaglino E, Cifaldi L, Di Carlo E, André A, Bernabei P, Musiani P, Forni G, Calogero RA.

Cancer Res. 2001 Apr 15;61(8):3518-23.

39.

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.

Cifaldi L, Quaglino E, Di Carlo E, Musiani P, Spadaro M, Lollini PL, Wolf S, Boggio K, Forni G, Cavallo F.

Cancer Res. 2001 Apr 1;61(7):2809-12.

40.

[Bioethics: what is the role of the physician and the professional nurse in the approach to the elderly cancer patient?].

Pastorelli R, Cifaldi L.

Minerva Med. 1999 Jul-Aug;90(7-8):268-70. Italian. No abstract available.

PMID:
10719436
41.

[Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].

Marchei P, Cifaldi L, De Benedetto A, Santini D, Manna A, Trasatti L, Marchei GG, Reale MG.

G Ital Oncol. 1990 Oct-Dec;10(4):121-4. Italian.

PMID:
2093080
42.

[Prostatic diseases: tumor markers (PAP and PSA) and age at risk].

Manna A, Trasatti L, Cifaldi L, Marchei GG, Reale MG, Marchei P.

J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):91. Italian. No abstract available.

PMID:
1709213
43.

HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention center.

Manzari V, Modesti M, De Marchis L, Gradilone A, Cifaldi L, Marchei P.

AIDS Res Hum Retroviruses. 1990 Mar;6(3):417-21.

PMID:
2340202
44.

[Evaluation of the effectiveness of preoperative antiblastic chemotherapy (neoadjuvant) in carcinoma of the bladder].

Cardi G, Cifaldi L, De Benedetto A, De Cesare A, Bononi M, Martinazzoli A, Marchei P.

Minerva Chir. 1988 May 31;43(10):855-9. Italian. No abstract available.

PMID:
3412623
45.

[Carcinoma of the penis. Review of the literature and presentation of a clinical case].

De Cesare A, Bononi M, Martinazzoli A, Cifaldi L, Cardi G, De Benedetto A.

G Chir. 1988 Feb;9(2):106-9. Review. Italian. No abstract available.

PMID:
3153968

Supplemental Content

Loading ...
Support Center